GLP-TZ is an investigational peptide compound being studied for its potential role in weight management, blood sugar regulation, and metabolic health.

GLP-TZ is generally described as a GLP-1 receptor-targeting peptide designed to mimic the effects of the body's natural incretin hormones.

These hormones help regulate glucose metabolism and appetite, making Tirzepatide 10 mg vial an area of interest for obesity and type 2 diabetes research.